144 related articles for article (PubMed ID: 187546)
1. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.
Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546
[TBL] [Abstract][Full Text] [Related]
2. Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension.
Messerli FH; Kuchel O; Hamet P; Tolis G; Guthrie GP; Fraysse J; Nowaczynski W; Genest J
Circ Res; 1976 Jun; 38(6 Suppl 2):42-7. PubMed ID: 178467
[TBL] [Abstract][Full Text] [Related]
3. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects.
Földes J; Gyertyánfy G; Piroska E; Juhász J
Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419
[TBL] [Abstract][Full Text] [Related]
4. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
[TBL] [Abstract][Full Text] [Related]
5. Glucagon: endocrine effects and calcium involvement in cardiovascular actions in dogs.
Chernow B; Reed L; Geelhoed GW; Anderson M; Teich S; Meyerhoff J; Beardsley D; Lake CR; Holaday JW
Circ Shock; 1986; 19(4):393-407. PubMed ID: 2427245
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of glucagon and isoproterenol induced cyclic 3'-5' adenosine monophosphate production in adipocytes isolated from the inguinal adipose tissue of developing rats.
Gaben AM; Jahchan T; Swierczewski W; Rosselin G
J Dev Physiol; 1982 Feb; 4(1):75-83. PubMed ID: 6179979
[TBL] [Abstract][Full Text] [Related]
8. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
12. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
Pun KK; Yeung CK; Ho PW; Lin HJ; Chan MK; Yeung RT
Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
[TBL] [Abstract][Full Text] [Related]
13. Conditions for augmentation of renin release by theophylline.
Langård O; Holdaas H; Eide I; Kiil F
Scand J Clin Lab Invest; 1983 Feb; 43(1):9-14. PubMed ID: 6312554
[TBL] [Abstract][Full Text] [Related]
14. Effect of alcohol on the plasma cAMP response to glucagon.
French SW; Ihrig TJ; Pettit NB
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):209-12. PubMed ID: 229531
[TBL] [Abstract][Full Text] [Related]
15. Impaired plasma cyclic AMP response to exogenous glucagon in acute liver injury.
Miyakoshi H; Noda Y; Uchida S; Tanaka N; Noto Y; Kato Y; Kawai K; Hayakawa H; Kobayashi K; Hattori N
J Clin Gastroenterol; 1984 Aug; 6(4):337-42. PubMed ID: 6090530
[TBL] [Abstract][Full Text] [Related]
16. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
Wellstein A; Belz GG; Palm D
J Pharmacol Exp Ther; 1988 Jul; 246(1):328-37. PubMed ID: 2839668
[TBL] [Abstract][Full Text] [Related]
17. The role of cyclic AMP in the inotropic response to isoprenaline and glucagon.
Oye I; Langslet A
Adv Cyclic Nucleotide Res; 1972; 1():291-300. PubMed ID: 4353172
[No Abstract] [Full Text] [Related]
18. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
Zaremba TG; Fishman PH
Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
